15 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
(Executive Director and above): 6.3% 6.5% 47.4% Black/African Hispanic/ Women American (U.S.) Latino (U.S.) (Global) 58%$1B Clinical trial sites in Global
DEFA14A
BMY
Bristol-Myers Squibb Co.
10 Apr 23
Additional proxy soliciting materials
5:12pm
in diverse metro areas 2022 Gender parity at executive level (VP+) globally 2X representation for Black/African American & Hispanic/Latino executives (VP … %) and Latino/Hispanic executives (VP+) (3.7% to 7.4%) in the U.S. by year-end 2022 Provide a 2-to-1 match through the Bristol Myers Squibb Foundation for U.S
8-K
EX-99.3
BMY
Bristol-Myers Squibb Co.
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
in diverse metro areas 2022 Gender parity at executive level 2X representation for Black/African American & Hispanic/Latino executives 2025 $1B spend
DEFA14A
08sy6ypsp vmxpkjxnot
20 Apr 22
Additional proxy soliciting materials
4:30pm
8-K
EX-99.3
9wg1ingad7
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am
8-K
EX-99.1
2avafrcg
16 Nov 21
Regulation FD Disclosure
9:20am
DEFA14A
hz1h9dz3 a2plmi
19 Apr 21
Additional proxy soliciting materials
7:41am
8-K
EX-99.1
lwrcu ny1
5 Nov 20
Bristol Myers Squibb Reports Third Quarter 2020 Financial Results
8:10am
- Prev
- 1
- Next